Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
NeuVitaz
- Development stage
- Unknown
- Lead developer
- Sanivo Biotec
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
NeuVitaz is an oral nutraceutical and vitamin combination capsule developed by Sanivo Biotec. It is formulated with methylcobalamin, alpha lipoic acid, benfotiamine, pyridoxine, folic acid, inositol, and chromium picolinate. NeuVitaz is indicated for the management of nutritional deficiencies and neurological disturbances, particularly diabetic neuropathy and other nerve-related ailments. The combination works synergistically to support nerve health, promote nerve regeneration, reduce oxidative stress, and improve cellular metabolism and energy production.
- Brand names
- NeuVitazNeuvitaz Capsule
- Other names
- Methylcobalamin + Alpha Lipoic Acid + Benfotiamine + Pyridoxine + Folic Acid + Inositol + Chromium Picolinatealpha lipoic acid + benfotiamine + chromium picolinate + folic acid + inositol + methylcobalamin + pyridoxine
02
Targets
MTR (Methionine synthase)DHFR (Dihydrofolate reductase)INSR (Insulin receptor)PDXK (Pyridoxal kinase)PDH (Pyruvate dehydrogenase complex)TKT (Transketolase)
Beyond the preview
Go deeper on NeuVitaz.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on NeuVitaz.